Cargando…

End-of-Life Care for End-stage Heart Failure Patients

Efforts to improve end-of-life (EOL) care have generally been focused on cancer patients, but high-quality EOL care is also important for patients with other serious medical illnesses including heart failure (HF). Recent HF guidelines offer more clinical considerations for palliative care including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ju-Hee, Hwang, Kyung-Kuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2022
Materias:	State of the Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470494/ https://www.ncbi.nlm.nih.gov/pubmed/36097835 http://dx.doi.org/10.4070/kcj.2022.0211

Ejemplares similares

Rethinking the withholding/withdrawing distinction: the cultural construction of “life-support” and the framing of end-of-life decisions
por: Barilan, Yechiel M
Publicado: (2015)

Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure
por: Kim, Kyung-Hee, et al.
Publicado: (2021)

Preventing new-onset heart failure: Intervening at stage A
por: Upadhya, Bharathi, et al.
Publicado: (2023)

Regulatory RNAs in Heart Failure
por: Gomes, Clarissa Pedrosa da Costa, et al.
Publicado: (2020)

Treatment Strategies of Improving Quality of Care in Patients With Heart Failure
por: Kim, Se-Eun, et al.
Publicado: (2023)

The Use of Machine Learning for the Care of Hypertension and Heart Failure
por: Cai, Anping, et al.
Publicado: (2021)

Cardiac rehabilitation for heart failure: ‘Cinderella’ or evidence-based pillar of care?
por: Taylor, Rod S, et al.
Publicado: (2023)

Breath of Life: Heart Disease Link to Developmental Hypoxia
por: Giussani, Dino A.
Publicado: (2021)

Metabolic Origins of Heart Failure
por: Wende, Adam R., et al.
Publicado: (2017)

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
por: Abovich, Arielle, et al.
Publicado: (2023)

Medical Management of Patients With Heart Failure and Reduced Ejection Fraction
por: Greenberg, Barry
Publicado: (2022)

Epigenetics in Cardiac Hypertrophy and Heart Failure
por: Liu, Chia-Feng, et al.
Publicado: (2019)

Effectiveness and Approach of Rehabilitation in Patients With Acute Heart Failure: A Review
por: Ueno, Kensuke, et al.
Publicado: (2022)

Electrical management of heart failure: from pathophysiology to treatment
por: Prinzen, Frits W, et al.
Publicado: (2022)

Targeting the Mitochondria in Heart Failure: A Translational Perspective
por: Sabbah, Hani N.
Publicado: (2020)

Iron and Heart Failure: Diagnosis, Therapies, and Future Directions
por: Ghafourian, Kambiz, et al.
Publicado: (2020)

Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes
por: Packer, Milton, et al.
Publicado: (2023)

Finding a Needle in a Haystack: Proteomics in Heart Failure
por: Michelhaugh, Sam A., et al.
Publicado: (2020)

A Glimpse Into the Future of Transcatheter Interventional Heart Failure Therapies
por: Cerrud-Rodriguez, Roberto C., et al.
Publicado: (2021)

Sodium-glucose Co-transporter 2 Inhibitors: a New Path for Heart Failure Treatment
por: Oh, Jaewon, et al.
Publicado: (2021)

Sudden Death and Ventricular Arrhythmias in Heart Failure With Preserved Ejection Fraction
por: Cho, Jae Hyung
Publicado: (2022)

Inefficient Batteries in Heart Failure: Metabolic Bottlenecks Disrupting the Mitochondrial Ecosystem
por: Schwartz, Brian, et al.
Publicado: (2022)

Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure
por: Yura, Yoshimitsu, et al.
Publicado: (2020)

The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
por: Macedo, Arthur C., et al.
Publicado: (2023)

Short-Chain Carbon Sources: Exploiting Pleiotropic Effects for Heart Failure Therapy
por: Challa, Azariyas A., et al.
Publicado: (2022)

Murine Models of Heart Failure With Preserved Ejection Fraction: A “Fishing Expedition”
por: Valero-Muñoz, Maria, et al.
Publicado: (2017)

Large Animal Models of Heart Failure: A Translational Bridge to Clinical Success
por: Silva, Kleiton Augusto Santos, et al.
Publicado: (2020)

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
por: Salah, Husam M., et al.
Publicado: (2021)

Levosimendan in the modern treatment of patients with acute heart failure of various aetiologies
por: Glinka, Lidia, et al.
Publicado: (2019)

Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models
por: van Ham, Willem B., et al.
Publicado: (2022)

Neprilysin Inhibitors in Heart Failure: The Science, Mechanism of Action, Clinical Studies, and Unanswered Questions
por: Bozkurt, Biykem, et al.
Publicado: (2022)

Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: Rosalia, Luca, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models
por: Withaar, Coenraad, et al.
Publicado: (2021)

Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction
por: Sinha, Aish, et al.
Publicado: (2021)

Dilemmas in end-stage heart failure
por: Chen-Scarabelli, Carol, et al.
Publicado: (2015)

Calcium Buffering in the Heart in Health and Disease
por: Smith, Godfrey L., et al.
Publicado: (2019)

Depression in late life
por: Barry, D. Lebowitz
Publicado: (1999)

Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series?
por: Cismaru, Andrei Cosmin, et al.
Publicado: (2020)

Heart failure in the diabetic population – pathophysiology, diagnosis and management
por: Kasznicki, Jacek, et al.
Publicado: (2014)

Obesity in patients with end-stage heart failure
por: Król, Bogumiła, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_snspbe7shqu4hhi6pgrdcvl1de